Wang, R., Smyth, L. M., Iyengar, N., Chandarlapaty, S., Modi, S., Jochelson, M., . . . Dang, C. T. (2019). Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up. Oncologist.
Chicago Style citaatWang, Rui, et al. "Phase II Study of Weekly Paclitaxel With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up." Oncologist 2019.
MLA citatieWang, Rui, et al. "Phase II Study of Weekly Paclitaxel With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5‐Year Follow‐up." Oncologist 2019.